Cefditoren: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:
'''| [[Cefditoren drug interactions|Drug Interactions]]'''
'''| [[Cefditoren drug interactions|Drug Interactions]]'''
'''| [[Cefditoren overdosage|Overdosage]]'''
'''| [[Cefditoren overdosage|Overdosage]]'''
'''| [[Cefditoren clinical studies|Clinical Studies]]'''
'''| [[Cefditoren dosage and administration|Dosage and Administration]]'''
'''| [[Cefditoren dosage and administration|Dosage and Administration]]'''
'''| [[Cefditoren how supplied|How Supplied]]'''
'''| [[Cefditoren how supplied|How Supplied]]'''

Revision as of 01:44, 6 January 2014

Cefditoren
SPECTRACEF® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.

Category

Cephasporin, Third-Generation

US Brand Names

SPECTRACEF®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

References